GNAS and non-small cell lung carcinoma: Furthermore, genes involved in the PKA pathway shown to be inhibited by BRB during experimental oral carcinogenesis (Crebbp, Gnas, and Ywhag) have been identified as possible targets for the treatment of HNSCC, breast, and non-small cell lung cancer [70,71,72].